AMTI Applied Molecular Transport Inc

Price (delayed)

$3.72

Market cap

$143.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.19

Enterprise value

$55.8M

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, ...

Highlights
Applied Molecular Transport's equity has decreased by 22% from the previous quarter but it has increased by 13% YoY
The net income has plunged by 71% YoY and by 22% from the previous quarter
The company's quick ratio fell by 44% YoY and by 39% QoQ

Key stats

What are the main financial stats of AMTI
Market
Shares outstanding
38.65M
Market cap
$143.79M
Enterprise value
$55.8M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.12
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$122.4M
EBITDA
-$112.98M
Free cash flow
-$96.09M
Per share
EPS
-$3.19
Free cash flow per share
-$2.49
Book value per share
$3.31
Revenue per share
$0
TBVPS
$4.7
Balance sheet
Total assets
$181.69M
Total liabilities
$53.84M
Debt
$39.51M
Equity
$127.85M
Working capital
$114.68M
Liquidity
Debt to equity
0.31
Current ratio
7.2
Quick ratio
6.89
Net debt/EBITDA
0.78
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-59.2%
Return on equity
-71.3%
Return on invested capital
-177.1%
Return on capital employed
-75%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMTI stock price

How has the Applied Molecular Transport stock price performed over time
Intraday
6.59%
1 week
28.72%
1 month
18.85%
1 year
-92.14%
YTD
-73.39%
QTD
-50.53%

Financial performance

How have Applied Molecular Transport's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$122.89M
Net income
-$122.4M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 71% YoY and by 22% from the previous quarter
Applied Molecular Transport's operating income has plunged by 71% YoY and by 22% from the previous quarter

Growth

What is Applied Molecular Transport's growth rate over time

Valuation

What is Applied Molecular Transport stock price valuation
P/E
N/A
P/B
1.12
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
AMTI's EPS is down by 25% year-on-year and by 19% since the previous quarter
AMTI's P/B is 78% below its last 4 quarters average of 4.8
Applied Molecular Transport's equity has decreased by 22% from the previous quarter but it has increased by 13% YoY

Efficiency

How efficient is Applied Molecular Transport business performance
The ROE has contracted by 39% YoY and by 20% from the previous quarter
The return on invested capital has declined by 32% since the previous quarter
Applied Molecular Transport's ROA has decreased by 23% YoY and by 14% from the previous quarter

Dividends

What is AMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMTI.

Financial health

How did Applied Molecular Transport financials performed over time
The company's total assets rose by 44% YoY but it fell by 15% QoQ
The company's quick ratio fell by 44% YoY and by 39% QoQ
Applied Molecular Transport's debt is 69% less than its equity
The debt to equity has grown by 29% since the previous quarter
Applied Molecular Transport's equity has decreased by 22% from the previous quarter but it has increased by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.